ClinicalTrials.Veeva

Menu

Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates (BOOST-CA)

I

Institut Paoli-Calmettes

Status

Completed

Conditions

Anal Canal Cancer

Treatments

Radiation: Brachytherapy

Study type

Observational

Funder types

Other

Identifiers

NCT03465501
BOOST-CA IPC 2017-016

Details and patient eligibility

About

Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting [low dose rate (LDR) and high dose rate (HDR)]

Full description

Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate, Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.

Enrollment

89 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients treated by brachytherapy anal canal to boost.

Exclusion criteria

  • Patients below age of 18 years

Trial design

89 participants in 2 patient groups

Low Dose Rate
Description:
Patients treated with brachytherapy at low dose rate of the anal canal with aim of boost
Treatment:
Radiation: Brachytherapy
High Dose Rate
Description:
Patients treated by brachytherapy with a high dose rate of the anal canal aiming for boost
Treatment:
Radiation: Brachytherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems